Načítá se...
Tumoricidal Effects of Macrophage-activating Immunotherapy in a Murine Model of Relapsed/ Refractory Multiple Myeloma
Myeloma remains a virtually incurable malignancy. The inevitable evolution of multi-drug resistant clones and widespread clonal heterogeneity limit the potential of traditional and novel therapies to eliminate minimal residual disease, a reliable harbinger of relapse. Here we show potent anti-myelom...
Uloženo v:
| Vydáno v: | Cancer Immunol Res |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4527950/ https://ncbi.nlm.nih.gov/pubmed/25941352 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-15-0025-T |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|